Literature DB >> 7999779

Effects of particle size on cell uptake of model triglyceride-rich particles with and without apoprotein E.

E Granot1, B Schwiegelshohn, I Tabas, M Gorecki, T Vogel, Y A Carpentier, R J Deckelbaum.   

Abstract

The effect of apoprotein E on cellular uptake of "VLDL-size" and "IDL-size" triacylglycerol-phospholipid emulsion particles was studied in J-774 macrophages and fibroblasts. In the absence of apoprotein E (apo E), uptake of the smaller IDL-size particles was up to 2-fold higher by mass and 100-fold higher as calculated by particle number. Apo E enhanced the uptake of both VLDL-size and IDL-size emulsion particles, but the effect was greater on the uptake of larger particles (4-5-fold) as compared to up to a 2-fold increase in the uptake of IDL-size particles. In fibroblasts, particle uptake was less than in macrophages (30-50%), but preferential uptake of smaller particles was similarly observed. Particle internalization was demonstrated by 125I-apo E degradation and resistance to particle release by heparin-suramin. In the absence of apo E, cholesteryl ester of emulsion particles (prepared with trace amounts of [3H]cholesteryl ester) was hydrolyzed to free cholesterol, proving internalization and intracellular metabolism. Double-label experiments using DiI-labeled emulsion particles, in the absence and presence of apo E, showed that emulsion particles are rapidly targeted to perinuclear lysosomes. Thus, at physiological concentrations of triglyceride-rich particles, non-receptor-mediated uptake is a mechanism for the uptake of VLDL-size and IDL-size particles into cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7999779     DOI: 10.1021/bi00254a030

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Increased sphingomyelin content of plasma lipoproteins in apolipoprotein E knockout mice reflects combined production and catabolic defects and enhances reactivity with mammalian sphingomyelinase.

Authors:  Ts Jeong; S L Schissel; I Tabas; H J Pownall; A R Tall; X Jiang
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

2.  Modulation of apolipoprotein E-mediated plasma clearance and cell uptake of emulsion particles by cholesteryl ester.

Authors:  H Saito; K Okuhira; N Tsuchimoto; A Vertut-Doi; C Matsumoto; T Tanimoto; S Okada; T Handa
Journal:  Lipids       Date:  2001-01       Impact factor: 1.880

3.  n-3, but not n-6 lipid particle uptake requires cell surface anchoring.

Authors:  Faith M Murray-Taylor; Yuan-Yuan Ho; Narumon Densupsoontorn; Chuchun L Chang; Richard J Deckelbaum; Toru Seo
Journal:  Biochem Biophys Res Commun       Date:  2010-01-07       Impact factor: 3.575

4.  CD36 and proteoglycan-mediated pathways for (n-3) fatty acid enriched triglyceride-rich particle blood clearance in mouse models in vivo and in peritoneal macrophages in vitro.

Authors:  Narumon Densupsoontorn; Yvon A Carpentier; Radjini Racine; Faith M Murray; Toru Seo; Rajasekhar Ramakrishnan; Richard J Deckelbaum
Journal:  J Nutr       Date:  2008-02       Impact factor: 4.798

5.  Fatty acid supplied as triglyceride regulates SRE-mediated gene expression as efficiently as free fatty acids.

Authors:  Narumon Densupsoontorn; Tilla S Worgall; Toru Seo; Hiroko Hamai; Richard J Deckelbaum
Journal:  Lipids       Date:  2007-08-07       Impact factor: 1.880

6.  N-3 fatty acid rich triglyceride emulsions are neuroprotective after cerebral hypoxic-ischemic injury in neonatal mice.

Authors:  Jill J Williams; Korapat Mayurasakorn; Susan J Vannucci; Christopher Mastropietro; Nicolas G Bazan; Vadim S Ten; Richard J Deckelbaum
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

Review 7.  Unraveling the enigma: elucidating the relationship between the physicochemical properties of aluminium-based adjuvants and their immunological mechanisms of action.

Authors:  Emma Shardlow; Matthew Mold; Christopher Exley
Journal:  Allergy Asthma Clin Immunol       Date:  2018-11-07       Impact factor: 3.406

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.